ABC
AVDL

Associated Banc-Corp’s Avadel Pharmaceuticals AVDL Stock Holding History

Associated Banc-Corp’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-500
Closed -$3K – 336
2020
Q4 		$3K Hold
500
– – ﹤0.01% 602
2020
Q3 		$3K Hold
500
– – ﹤0.01% 516
2020
Q2 		$4K Hold
500
– – ﹤0.01% 443
2020
Q1 		$4K Buy
+500
New +$3.84K ﹤0.01% 421

Other funds holding AVDL

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
PCH
Polar Capital Holdings London, United Kingdom $28.2B AUM 115.26% 1-Year Est. Return
CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
GJL
Gendell Jeffrey L $7.34B AUM 183.72% 1-Year Est. Return
ACP
Acuta Capital Partners Redwood City, California $142M AUM 783.79% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
ACM
Asymmetry Capital Management San Francisco, California $188M AUM 44.72% 1-Year Est. Return

Associated Banc-Corp's AVDL Position: Q1 2021 in Review

Associated Banc-Corp sold out of Avadel Pharmaceuticals (AVDL) in Q1 2021, closing a stake of 500 shares — an estimated $3K sold.

Associated Banc-Corp first reported a position in AVDL in Q1 2020 and held it in 4 quarters. The position peaked at $4K in Q2 2020. 76 funds tracked by Wall St. Rank hold AVDL as of Q1 2021.

  • Associated Banc-Corp reported no remaining Avadel Pharmaceuticals position as of Q1 2021 after selling out during the quarter.
  • Associated Banc-Corp sold 500 Avadel Pharmaceuticals shares in Q1 2021, an estimated $3K.
  • Associated Banc-Corp first reported a position in Avadel Pharmaceuticals in Q1 2020 and held it in 4 quarters.
  • Associated Banc-Corp's Avadel Pharmaceuticals position peaked at $4K in Q2 2020.
  • 76 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2021.

Based on Associated Banc-Corp's 13F filing for Q1 2021, filed 5 May 2021.